Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7302-7310

  Chen, Yijun ^a   Shi, Gongyi ^a   Xia, Wei ^b   Kong, Christina ^c   Zhao, Shuchun ^c   Gaw, Allison F ^a   Chen, Eunice Y ^d   Yang, George P ^b   Giaccia, Amato J ^a   Le, Quynh Thu ^a   Koong, Albert C ^a,d  

^a Center for Clinical Sciences Research   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CORTACTIN; DENSITY REGULATED PROTEIN 1; DIHYDROFOLATE REDUCTASE; ENOLASE; HEAT SHOCK PROTEIN 27; HYPOXIA INDUCIBLE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MOESIN; NUCLEAR TRANSPORT FACTOR 2; PAXILLIN; PENTRAXIN; PROTEIN; PROTEIN HIF 1ALPHA; PROTEIN IKKBETA; PROTEIN JUN; PROTEIN MKK3B; PROTEIN P 150; PROTEIN P27; PROTEIN P53; PROTEIN SNX1; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BIOASSAY; CANCER THERAPY; CELL SURVIVAL; CONTROLLED STUDY; DISEASE MARKER; DRUG TARGETING; FEMALE; GEL ELECTROPHORESIS; GENETIC TRANSCRIPTION; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; MALE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; OXYGENATION; POWERBLOT ASSAY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEOMICS; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; CELL LINE, TUMOR; CORTACTIN; FEMALE; HEAD AND NECK NEOPLASMS; HEAT-SHOCK PROTEINS; HUMANS; I-KAPPA B KINASE; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; OXYGEN; PROTEIN-SERINE-THREONINE KINASES; PROTEOMICS; TISSUE ARRAY ANALYSIS; UP-REGULATION;

EID: 5644282650     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0899     Document Type: Article

References (34)

1. Brizel D, Prosnitz L, Scher R, Dewhirst M. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1997;38: 285-9.
2. Brizel DM, Dodge RK, Clough RW, Dewhirst MW. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 1999;53:113-7.
3. Brizel D, Harrelson J, Layfield L, Bean J, Prosnitz L, Dewhirst M. Tumor oxygenation predicts for likelihood of distant metastasis in human soft tissue sarcoma. Cancer Res 1996;56:941-3.
4. Hockel M, Aral B, Mitze M, Schaffer U, Vaupel P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res 1996;56:4509-15.
5. Nordsmark M, Overgaard M, Overgaard J. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1996;41:31-9.
6. Graeber T, Osmanian C, Jacks T, et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature (Lond.) 1996;379:88-91.
7. Koong AC, Denko NC, Hudson KM, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883-7.
8. Young S, Hill R. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci USA 1988;85:9533-7.
9. Subarsky F, Hill R. The hypoxic tumor microenvironment and metastatic progression. Clin Exp Metastasis 2003;20:237-50.
10. Vaupel P, Kelleher D, Hockel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol 2001;28:29-35.
11. Brown J. Tumor microenvironment an the response to anticancer therapy. Cancer Biol Ther 2002;1:453-8.
12. Denko NC, Fontana LA, Hudson KM, et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene 2003;22:5907-14.
13. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-30.
14. Chen G, Gharib TG, Huang CC, et al. Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 2002;1:304-13.
15. Srinivas P, Srivastava S, Hanash S, Wright G. Proteomics in early detection of cancer. Clin Chem 2001;47:1901-11.
16. Evans SM, Koch CJ. Prognostic significance of tumor oxygenation in humans. Cancer Lett 2003;195:1-16.
17. Hooper N. Protein purification from animal tissue. In: RS, editor. Protein purification applications, 2 ed. Oxford University Press; 2001. p. 119-22.
18. Chaturvedi M, LaPushin R, Aggarwal B. Tumor necrosis factor and lymphotoxin: qualitative and quantitative differences in the mediation of early and late cellular response. J Biol Chem 1994;269:14575-83.
19. Liu CL, Prapong W, Natkunam Y, et al. Software tools for high-throughput analysis and archiving of immunohistochemistry staining data obtained with tissue microarrays. Am J Pathol 2002;161:1557-65.
20. Terris DJ, Dunphy E. Oxygen tension measurements of head and neck cancers. Arch Otolaryngol Head Neck Surg 1994;120:283-7.
21. Becker A, Hansgen G, Bloching M, Weigel C, Lautenschlager C, Dunst J. Oxygenation of squamous cell carcinoma of the head and neck: comparison of primary tumors, neck node metastases, and normal tissue. Int J Radiat Oncol Biol Phys 1998;42:35-41.
22. Glanz S, Slinker B. Primer of applied regression analysis of variance. New York: McGraw-Hill, Inc.; 1990. p. 50-109, 512-168.
23. Koumenis C, Naczki C, Koritzinsky M, et al. Regulation of protein synthesis by hypoxia via activation of the endoplasmic reticulum kinase PERK and phosphorylation of the translation initiation factor eIF2alpha. Mol Cell Biol 2002;22:7405-16.
24. Kucharczak J, Simmons MJ, Fan Y, Gelinas C. To be, or not to be: NF- kappaB is the answer - role of Rel/NF-kappaB in the regulation of apoptosis. Oncogene 2003;22: 8961-82.
25. Koong AC, Chen EY, Giaccia AJ. Hypoxia causes the activation of nuclear factor kappa B through the phosphorylation of 1 kappa B alpha on tyrosine residues. Cancer Res 1994;54:1425-30.
26. Koong A, Chen E, Mivechi N, Denko N, Stambrook P, Giaccia A. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK 1 or ERK 2). Cancer Res 1994;54:5273-9.
27. Ivan M, Kondo K, Yang H, et al. HIF alpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science (Wash. DC) 2001; 292:464-8.
28. Jaakkola P, Mole DR, Tian YM, et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science (Wash. DC) 2001;292:468-72.
29. Chan D, Sutphin PD, Denko NC, Giaccia AJ. Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1alpha. J Biol Chem 2002;277: 40112-7.
30. Li Q, Van Antwerp D, Mercurio F, Lee K, Verma I. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science (Wash. DC) 1999;284:321-5.
31. Brown J, Wilson W. Exploiting tumour hypoxia in cancer treatment. Nat Rev Cancer 2004;4:437-47.
32. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suarez C. EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 2000;6:3177-82.
33. Nakukuki K, Imoto I, Pimkhaokham A, et al. Novel targets for the 18p11.2 amplification frequently observed in esophageal squamous cell carcinomas. Carcinogenesis (Lond.) 2002;23:19-24.
34. Chen Y, Riley DJ, Chen PL, Lee WH. HEC, a novel nuclear protein rich in leucine heptad repeats specifically involved in mitosis. Mol Cell Biol 1997;17:6049-56.